SCHEMBL22475682

SCHEMBL22475682

COC(=O)c1cnn2ccc(CN3NNc4ncc(-c5cnn(CCO)c5)nc43)cc12

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MET P08581 9/20 0.42
FGFR1 P11362 10/20 0.36
FGFR3 P22607 10/20 0.36
KDR P35968 9/20 0.36
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
CYP2C9 P11712 1/20 0.36
PDE10A Q9Y233 1/20 0.36
FGFR2 P21802 6/20 0.35
FGFR4 P22455 6/20 0.35
SYK P43405 1/20 0.34
FLT3 P36888 1/20 0.34
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16882542 0.85 MET (0.46) METFGFR1FGFR3KDRPDE3B
SCHEMBL16882496 0.83 MET (0.45) METFGFR1FGFR3KDRPDE3B
SCHEMBL12689736 0.81 MET (0.66) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL17425935 0.80 MET (0.48) METFGFR1FGFR3KDRPDE3B
SCHEMBL21167668 0.78 CSF1R (0.41) METFGFR1FGFR3KDRFGFR2
SCHEMBL21167664 0.77 EGFR (0.40) METFGFR1FGFR3KDRFGFR2
SCHEMBL16882492 0.75 MET (0.53) METFGFR1FGFR3KDRPDE3B
SCHEMBL19261423 0.73 MET (0.65) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL16587106 0.73 MET (0.62) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL24591133 0.73 MET (0.47) METFGFR1FGFR3KDRPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed